Lecanemab (marketed as Leqembi) is today’s top Alzheimer’s drug. Why does equitable access to this drug remain a significant challenge? What needs to be done?
MEDICATION VIDEO:
How do you know when Alzheimer’s meds ought to be stopped? Explore the benefits of these medications, such as improved cognition, memory, behavior, lifespan, and the stages they are most effective.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Alzheimer’s rates are on the rise. How is today’s best treatment, Leqembi (generic lecanemab) doing in the fight against it?
See why Leqembi is even more effective in males than females, at fighting Alzheimer’s.
The European Union authorizes Leqembi as its very first Alzheimer’s drug to target an underlying cause of Alzheimer’s.
The new Alzheimer’s antibodies, Leqembi and Kisunla, work better on some people than others. A cutting-edge technique called spatial transcriptomics may help figure out how to make them work better for everybody.
ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.
A new analysis of the benefits of these Alzheimer’s treatments scores the days and ways patients succeed in living independently.
The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.
The diagnostic and treatment network behind Leqembi may be its biggest competitive edge.
Dementia creates difficult moments when responding to delusions. Watch how Teepa Snow, Dementia Care Specialist, provides strategies to manage these situations with respect and dignity.
Verna and Jerry Kinersly were happily married for nearly 68 years. See why they were glad to have found the Lou Ruvo Center for Brain Health.
One woman held the genetic key to unlock the mystery of how she was the only one free of early-onset Alzheimer’s, out of 1,200 members of a South American family,
Researchers say it takes a dozen “intervention sessions” to improve cognition in those at risk for Alzheimer’s and other dementias.
FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.
This carpool sing-a-long between a father with dementia and his son went viral. $50,000 in donations poured into the Alzheimer’s Society. Enjoy their great music. Sing along if you can!
No spam, only news and updates.
